Home/Filings/4/0001053369-18-000004
4//SEC Filing

Ward Carter Julian 4

Accession 0001053369-18-000004

CIK 0001053369other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:59 PM ET

Size

5.1 KB

Accession

0001053369-18-000004

Insider Transaction Report

Form 4
Period: 2018-02-26
Ward Carter Julian
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-02-26$0.12/sh+242,060$29,9912,127,364 total
Holdings
  • Common Stock

    (indirect: By IRA)
    1,355,014

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeother

Related Parties

1
  • filerCIK 0001467874

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:59 PM ET
Size
5.1 KB